Author

A. Kersbergen

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Batrouney· 1 shared A. Gasparini· 1 shared A. Kucukosmanoglu· 1 shared C. Khoo· 1 shared G. Borst· 1 shared J. Jonkers· 1 shared J. Minna· 1 shared J. Ng· 1 shared

Activity by Year

2018-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Batrouney

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivOct 9, 2022

Brief report: Reclassifying SCLC-Y as SMARCA4 deficient malignancies - resolving the controversy

J. Ng, L. Cai, L. Girard…·K. D. Sutherland

The paper reclassifies YAP1-expressing SCLC-Y as SMARCA4-deficient malignancies, showing they lack SCLC features and instead resemble SMARCA4-deficient tumors.

DOI 10.1158/1078-0432.ccr-23-2360

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivJul 17, 2018

Radiosensitivity is an acquired vulnerability of PARPi-resistant BRCA1-deficient tumors

M. Barazas, A. Gasparini, Y. Huang…·S. Rottenberg

This study identifies radiotherapy as a therapeutic target for BRCA1-deficient tumors that have developed resistance to PARP inhibitors through 53BP1 pathway inactivation.

DOI 10.1158/0008-5472.can-18-2077

mouseexperimental assay

𝕏 PostBluesky